Zoe R Maylin

3PUBLICATIONS
7CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 24, 2026
Correction: Maylin et al. Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer. Cells 2024, 13, 1999.

|Dec 17, 2024
Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer.

Zoe R Maylin, Christopher Smith, Adam Classen

|Oct 27, 2022
Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance.

Radu Costin Bizga Nicolescu, Zoe R Maylin, Francisco Javier Pérez-Areales

Pageof 1

Frequent Collaborators

2 joint publications

Mohammad Asim

2 joint publications

Christopher Smith

2 joint publications

Yuzhuo Wang

1 joint publications

Radu Costin Bizga Nicolescu